GoldenGolden
Advanced Search
Genentech

Genentech

Biotechnology company that discovers, develops, manufactures and commercializes therapeutic products for serious or life-threatening medical conditions. Disease areas include oncology, immunology, ophthalmology, metabolism and virology. Genentech has been a member of the Roche Group since 2009.

In 2009 Genentech became a member of the Roche Group and the two companies combined their pharmaceutical operations in the US. The San Francisco campus of Genentech serves as headquarters for Roche pharmaceutical operations in the US. Operating as an independent center within Roche is Genentech Research and Early Development.

Genentech was founded by Robert A. Swanson (1947-1999), a venture capitalist, and biochemist Dr. Herbert W. Boyer. Boyer along with Stanley Cohen were pioneers in recombinant DNA technology.

Genetech has drug manufacturing facilities in South San Francisco, Vacaville and Oceanside, California. Genetech focused on large-scale biologics and products for about 30 years. A shift towards developing therapies that target smaller patient populations began around 2013. Genentech has two commercial large volume products, Herceptin and Rituxan, of which they produce more than 2000 kg per year. The company has six products that classify as standard volume products, between 300 kg and 2000 kg per year, as well as three in clinical trials. As of 2019 Genetech had four products considered small volume, less than 300 kg per year, and nine small volume products in the pipeline.

Genentech is developing a virtual reality simulator for eye surgery.

Products
Biooncology

Alecensa® (alectinib)

Avastin® (bevacizumab)

Cotellic® (cobimetinib)

Erivedge® (vismodegib)

Gazyva® (obinutuzumab)

Herceptin® (trastuzumab)

Herceptin Hylecta™ (trastuzumab and hyaluronidase-oysk)

Kadcyla® (ado-trastuzumab emtansine)

Perjeta® (pertuzumab)

Rituxan® (rituximab [Oncology])

Rituxan Hycela™ (rituximab and hyaluronidase human)

Tarceva® (erlotinib)

Tecentriq® (atezolizumab)

Venclexta® (venetoclax)

Xeloda® (capecitabine)

Zelboraf® (vemurafenib)

Immunology and Ophthalmology

Actemra® (tocilizumab)

Esbriet® (pirfenidone)

Lucentis™ (ranibizumab injection)

Rituxan® (rituximab [Immunology])

Xolair® (omalizumab)

Metabolism and Primary Care

Activase® (alteplase)

Cathflo Activase® (alteplase)

Nutropin AQ® (somatropin (rDNA origin) for injection)

TNKase® (tenecteplase)

Neurology

Ocrevus® (ocrelizumab)

Virology and Specialty Care

CellCept® (mycophenolate mofetil)

Pegasys® (peginterferon alfa-2a)

Pulmozyme® (dornase alfa)

Tamiflu® (oseltamivir phosphate)

Valcyte® (valganciclovir hydrochloride)

Xofluza ™ (baloxavir marboxil)

Other

Boniva Injection® (ibandronate sodium)

Boniva Tablets® (ibandronate sodium)

Cytovene® (ganciclovir)

Fuzeon® (enfuvirtide)

Hemlibra® (emicizumab-kxwh)

Invirase® (saquinavir mesylate)

Klonopin® (clonazepam)

Valium® (diazepam)

Timeline

November 23, 2020
OneOncology and Genentech announce the first clinical trial available to patients through OneR, the OneOncology Research Network.
May 18, 2020
Flatiron Health, Foundation Medicine, and Genentech partner to launch Novel Prospective Lung Cancer Clinical Study.
1976
Genentech raises a $100,000 seed round from Kleiner Perkins Caufield & Byers.

Funding rounds

People

Name
Role
LinkedIn

aakanksha patel

Employee

Aaron Yip

Employee

Aashima Singhal

Founder

Abraham Gacad

Employee

Adam Tomashek

Employee

Adhithya Mohanraj

Employee

Adilet Matkerimov

Employee

Adrian Jubb

Employee

Adriana Delor

Employee

Ajay Kshatriya

Employee

AKASH ARYA

Employee

Akila Gopalakrishnan

Employee

Akila Subramanian

Employee

Akiyo Marukawa

Previous Employee

Alan C Pikna

Employee

Alan Pruitt

Employee

Alec Howard

Employee

Alefiyah Shambhoora

Employee

Alekhya Akkunuri

Employee

Alex Bash

Employee

Alex Fischer

Employee

Alex Pomerantz

Employee

Alex Smoligovets

Employee

Alexander Kislukhin

Employee

Alexander Kozintsev

Employee

Page 1 of 27
...

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Alex Keown
July 8, 2021
BioSpace
The two were charged with conspiracy to commit trade secret theft and wire fraud, international money laundering and obstruction of justice.
Alex Keown
June 25, 2021
BioSpace
Roche had a big week, scoring wins but also stepping away from its gene therapy partnership with 4D Molecular Therapeutics.
Curis, Inc.
June 25, 2021
www.prnewswire.com:443
/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...
DelveInsight Business Research, LLP
June 24, 2021
www.prnewswire.com:443
/PRNewswire/ -- DelveInsight's Chronic Obstructive Pulmonary Disease (COPD) Market report puts forward a detailed perspective on epidemiology, current...
Ben Adams
June 24, 2021
FierceBiotech
Roche's biotech arm Genentech has created a new coalition of clinical research sites aimed at boosting diversity in oncology studies.
BioSpace
June 17, 2021
BioSpace
Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB).
June 10, 2021
BioSpace
Ambrx Announces Formation and Members of Scientific Advisory Board - read this article along with other careers information, tips and advice on BioSpace
Gail Dutton
June 9, 2021
BioSpace
BioSpace caught up with Charles Fuchs, M.D., SVP, Global Head of Oncology & Hematology Product Development, Genentech during the ASCO meeting.
Alex Keown
June 4, 2021
BioSpace
Biopharma and life sciences organizations strengthen their leadership teams and board with these Movers & Shakers.
BioSpace
June 3, 2021
BioSpace
Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer, today announced Georgia Erbez and Christy Oliger have joined the Company's Board of Directors.
BioSpace
June 3, 2021
BioSpace
Imago BioSciences, Inc. ("Imago"), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today announced the appointment of Wan-Jen Hong, M.D., as chief medical officer.
Cynthia Burks
June 2, 2021
Harvard Business Review
Four lessons from Genentech's 14-year journey.
Alex Keown
May 28, 2021
BioSpace
The biopharma industry strives to bring in more voices at the corporate level and clinical trials. But, there is still a long way to go, especially with companies helmed by minorities.
BioSpace
May 27, 2021
BioSpace
Erasca, a clinical-stage precision oncology company whose mission is to erase cancer and that is singularly focused on advancing therapies for patients with RAS/MAPK pathway-driven cancers, announced the expansion of its leadership team with key hires in finance, business development, operations, legal, regulatory, manufacturing, clinical pharmacology and data science.
Kyle LaHucik
May 25, 2021
FierceBiotech
Pieris Pharmaceuticals has tapped another Big Pharma in its collaboration efforts, this time striking a $20 million upfront deal with Roche's Genentech.
BioSpace
May 19, 2021
BioSpace
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced interim results from the Phase III IMpower010 study
Mark Terry
May 14, 2021
BioSpace
Life science jobs are booming in several regions around the U.S. One is the Pacific Northwest, specifically Oregon; another is the Philadelphia area. Here's a look.
Mark Terry
May 14, 2021
BioSpace
Life science jobs are booming in several regions around the U.S. One is the Pacific Northwest, specifically Oregon; another is the Philadelphia area. Here's a look.
Curis, Inc.
May 12, 2021
www.prnewswire.com:443
/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...
DelveInsight Business Research, LLP
May 12, 2021
www.prnewswire.com:443
/PRNewswire/ -- DelveInsight's Diabetic Retinopathy Market Insights report offers detailed information on current treatment practices, emerging drugs, Diabetic...
SHOW MORE

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.